[Possibilities and limits of oral diabetes therapy].
D000284:Administration, Oral; D001645:Biguanides / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D003927:Diet, Diabetic; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use
D001645:Biguanides; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds
Möglichkeiten und Grenzen der oralen Diabetestherapie.